中国中西医结合急救杂志
中國中西醫結閤急救雜誌
중국중서의결합급구잡지
Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care
2015年
6期
643-646
,共4页
陈光强%陈凯%雷燕尼%赵经纬%石广志
陳光彊%陳凱%雷燕尼%趙經緯%石廣誌
진광강%진개%뢰연니%조경위%석엄지
万古霉素%持续静脉注射%间断静脉注射%脑脊液%药代动力学
萬古黴素%持續靜脈註射%間斷靜脈註射%腦脊液%藥代動力學
만고매소%지속정맥주사%간단정맥주사%뇌척액%약대동역학
Vancomycin%Continuous intravenous infusion%Interim intravenous infusion%Cerebrospinal fluid%Pharmacokinetics
目的:比较神经外科手术患者术后持续静脉注射和间断静脉注射应用万古霉素时脑脊液中的药代动力学特征。方法选择首都医科大学附属北京天坛医院20例神经外科术后进入重症加强治疗病房(ICU)且接受万古霉素预防颅内感染治疗的患者,用简单随机化方法将患者分为持续静脉注射和间断静脉注射万古霉素两组,每组10例。持续静脉注射组患者开始静脉泵入15 mg/kg负荷剂量万古霉素1~2 h,随后以30 mg/kg的剂量匀速泵入24 h;间断注射组患者以15 mg/kg万古霉素泵入1~2 h,然后每12 h 1次。采用二维液相色谱法测定两组患者不同时间点的脑脊液中万古霉素的浓度,计算其药代动力学参数,并观察其不良反应。结果持续静脉注射组药物浓度-时间曲线下面积(AUC)和最低抑菌浓度(MIC)的比值与间断静脉注射组比较差异无统计学意义(19.7±14.0比16.1±6.4,P>0.05)。但持续静脉注射组脑脊液药物浓度12 h就能达到峰浓度(0.96±0.77)μg/mL,后达到了稳态浓度0.91~0.93μg/mL,并持续12 h;而间断静脉注射组脑脊液16 h 才达到峰浓度(0.92±0.47)μg/mL,随后2 h下降至(0.84±0.45)μg/mL,并仍然呈持续下降趋势。所有患者均未发现与用药相关的不良反应。结论持续静脉注射和间断注射万古霉素两种用药方法在神经外科术后无颅内感染患者中,脑脊液中能达到同样的药物效果,但持续静脉注射给药能较快达到峰浓度,而且随后的浓度波动较小。
目的:比較神經外科手術患者術後持續靜脈註射和間斷靜脈註射應用萬古黴素時腦脊液中的藥代動力學特徵。方法選擇首都醫科大學附屬北京天罈醫院20例神經外科術後進入重癥加彊治療病房(ICU)且接受萬古黴素預防顱內感染治療的患者,用簡單隨機化方法將患者分為持續靜脈註射和間斷靜脈註射萬古黴素兩組,每組10例。持續靜脈註射組患者開始靜脈泵入15 mg/kg負荷劑量萬古黴素1~2 h,隨後以30 mg/kg的劑量勻速泵入24 h;間斷註射組患者以15 mg/kg萬古黴素泵入1~2 h,然後每12 h 1次。採用二維液相色譜法測定兩組患者不同時間點的腦脊液中萬古黴素的濃度,計算其藥代動力學參數,併觀察其不良反應。結果持續靜脈註射組藥物濃度-時間麯線下麵積(AUC)和最低抑菌濃度(MIC)的比值與間斷靜脈註射組比較差異無統計學意義(19.7±14.0比16.1±6.4,P>0.05)。但持續靜脈註射組腦脊液藥物濃度12 h就能達到峰濃度(0.96±0.77)μg/mL,後達到瞭穩態濃度0.91~0.93μg/mL,併持續12 h;而間斷靜脈註射組腦脊液16 h 纔達到峰濃度(0.92±0.47)μg/mL,隨後2 h下降至(0.84±0.45)μg/mL,併仍然呈持續下降趨勢。所有患者均未髮現與用藥相關的不良反應。結論持續靜脈註射和間斷註射萬古黴素兩種用藥方法在神經外科術後無顱內感染患者中,腦脊液中能達到同樣的藥物效果,但持續靜脈註射給藥能較快達到峰濃度,而且隨後的濃度波動較小。
목적:비교신경외과수술환자술후지속정맥주사화간단정맥주사응용만고매소시뇌척액중적약대동역학특정。방법선택수도의과대학부속북경천단의원20례신경외과술후진입중증가강치료병방(ICU)차접수만고매소예방로내감염치료적환자,용간단수궤화방법장환자분위지속정맥주사화간단정맥주사만고매소량조,매조10례。지속정맥주사조환자개시정맥빙입15 mg/kg부하제량만고매소1~2 h,수후이30 mg/kg적제량균속빙입24 h;간단주사조환자이15 mg/kg만고매소빙입1~2 h,연후매12 h 1차。채용이유액상색보법측정량조환자불동시간점적뇌척액중만고매소적농도,계산기약대동역학삼수,병관찰기불량반응。결과지속정맥주사조약물농도-시간곡선하면적(AUC)화최저억균농도(MIC)적비치여간단정맥주사조비교차이무통계학의의(19.7±14.0비16.1±6.4,P>0.05)。단지속정맥주사조뇌척액약물농도12 h취능체도봉농도(0.96±0.77)μg/mL,후체도료은태농도0.91~0.93μg/mL,병지속12 h;이간단정맥주사조뇌척액16 h 재체도봉농도(0.92±0.47)μg/mL,수후2 h하강지(0.84±0.45)μg/mL,병잉연정지속하강추세。소유환자균미발현여용약상관적불량반응。결론지속정맥주사화간단주사만고매소량충용약방법재신경외과술후무로내감염환자중,뇌척액중능체도동양적약물효과,단지속정맥주사급약능교쾌체도봉농도,이차수후적농도파동교소。
Objective To compare the difference in pharmacokinetics characteristics of vancomycin in cerebrospinal fluid between administration by continuous infusion and interim infusion.Methods Twenty postoperative patients in the Department of Neurosurgery of Beijing Tiantan Hospital, Capital Medical University admitted into intensive care unit (ICU) to receive vancomycin for prophylaxis of intracranial infection were enrolled, and they were randomly distributed to a continuous intravenous infusion group and a interim intravenous infusion group, each group 10 cases. In continuous intravenous infusion group, the patients received a loading dose of vancomycin (15 mg/kg) by continuous intravenous pump infusion for 1 - 2 hours followed by 30 mg/kg vancomycin in a constant pump infusion rate for 24 hours; while in interim intravenous infusion group, the patients received 15 mg/kg vancomycin administered by intravenous pump infusion for 1 - 2 hours, once every 12 hours. The concentration of vancomycin in the cerebrospinal fluid at different time points was measured by two-dimensional liquid chromatography (2D-LC) method, the parameters of pharmacokinetics were calculated in the two groups, and the adverse reaction was observed.Results The comparison between the ratio of areas under the concentration-time curves (AUC) and minimum inhibitory concentration (MIC) of the continuous and interim groups showed no significant difference (19.7±14.0 vs. 16.1±6.4,P > 0.05). However, in the continuous intravenous infusion group, the drug concentration reached the peak value (0.96± 0.77)μg/mL at 12 hours, and later revealed a plateau concentration 0.91-0.93μg/mL for 12 hours; while in the intravenous infusion interim group, the drug concentration reached the peak value (0.92±0.47)μg/mL at 16 hours, in the later 2 hours declined to (0.84±0.45)μg/mL, and afterwards still had a tendency of persistent declination. In all the patients, no any adverse reaction related to the drug occurred.Conclusion Continuous intravenous infusion and interim intravenous infusion of vancomycin for the postoperative neurosurgical patients without intracranial infection have the similar efficacy of medication, but the former can achieve the peak concentration faster and later the fluctuation of drug concentration in cerebrospinal fluid is smaller than those in the latter.